Research map: Implementation and Audit of Mainstream Genetic Testing Within a High‐Volume UK Breast Unit for Pathogenic Variations Associated With Breast Cancer Using the R208 and R444.1 National Test Directory Criterion

Back to the article

Papers in this map

  1. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology · Sue M. Richards · 2015 · 33500 citations · Cited by this paper
  2. Real‐World Practice Patterns in Diagnosis and First‐Line Treatment in Metastatic Breast Cancer · 2026 · Related
  3. A Population-Based Study of Genes Previously Implicated in Breast Cancer · Chunling Hu · 2021 · 899 citations · Cited by this paper
  4. Extreme Nipple‐Sparing Mastectomy: Feasibility of Nipple Preservation and Immediate Reconstruction in Breasts Weighing Over 600 Grams in a Cohort of 43 Patients · 2025 · Related
  5. Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients With Early-Onset Breast Cancer · Julian Peto · 1999 · 883 citations · Cited by this paper
  6. Akkermansia muciniphila –Driven ceRNA Networks Regulate Immune Modulation and Breast Cancer Progression · 2025 · Related
  7. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors · Andrew Lee · 2019 · 770 citations · Cited by this paper
  8. Clinical Characteristics and Prognostic Risk Factors in Breast Cancer With Liver Metastasis · 2026 · Related
  9. Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer · Nadine Tung · 2016 · 574 citations · Cited by this paper
  10. Programmed Death Ligand 1 (PDL1) Expression in Neoadjuvant Triple‐Negative Breast Cancer: Association With Chemotherapy Response and Residual Cancer Burden · 2025 · Related
  11. Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study · Ellen Copson · 2018 · 510 citations · Cited by this paper
  12. Diagnosis of Benign and Malignant Newly Developed Nodules on the Surgical Side After Breast Cancer Surgery Based on Machine Learning · 2025 · Related
  13. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer · Charles E. Geyer · 2022 · 477 citations · Cited by this paper
  14. Skin Involvement of Idiopathic Granulomatous Mastitis: Sonographic, Clinical, and Histopathological Features · 2025 · Related
  15. Next-generation sequencing and its clinical application · Qin Dahui · 2019 · 341 citations · Cited by this paper
  16. CanRisk Tool—A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants · Tim Carver · 2021 · 242 citations · Cited by this paper
  17. Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline · Isabelle Bedrosian · 2024 · 211 citations · Cited by this paper
  18. All in the family: Evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results · Chanita Hughes · 2001 · 206 citations · Cited by this paper
  19. Communication of BRCA1 and BRCA2 results to at‐risk relatives: A cancer risk assessment program's experience · Josephine Wagner Costalas · 2003 · 132 citations · Cited by this paper
  20. Tumor Protein p53 (TP53) Testing and Li-Fraumeni Syndrome · April Sorrell · 2013 · 108 citations · Cited by this paper
  21. A literature review of the psychological impact of genetic testing on breast cancer patients · Kathryn J. Schlich‐Bakker · 2005 · 102 citations · Cited by this paper
  22. Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study · Stephanie Archer · 2020 · 86 citations · Cited by this paper
  23. Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study · Eva Blondeaux · 2025 · 56 citations · Cited by this paper
  24. Motivations and barriers to pursue cancer genomic testing: A systematic review · Megan Smith-Uffen · 2020 · 53 citations · Cited by this paper
  25. Associations between Single Nucleotide Polymorphisms in Double-Stranded DNA Repair Pathway Genes and Familial Breast Cancer · Mary Elizabeth Sehl · 2009 · 41 citations · Cited by this paper
  26. BRCA genetic testing and counseling in breast cancer: how do we meet our patients’ needs? · Peter Christian Dubsky · 2024 · 40 citations · Cited by this paper
  27. CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate Cancer · Tommy Nyberg · 2022 · 35 citations · Cited by this paper
  28. Does mainstream BRCA testing affect surgical decision-making in newly-diagnosed breast cancer patients? · Quratul Ain · 2022 · 24 citations · Cited by this paper
  29. Germline Genetic Testing for Women With Breast Cancer: Shifting the Paradigm From Whom to Test to Whom NOT to Test · Nadine Tung · 2021 · 16 citations · Cited by this paper
  30. Does Mastectomy Reduce Overall Survival in Early Stage Breast Cancer? · James Oliver Murphy · 2021 · 10 citations · Cited by this paper
  31. BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trial · Bethany Torr · 2024 · 10 citations · Cited by this paper
  32. Hereditary genetic testing and mainstreaming: a guide for surgeons · A Monaghan · 2024 · 9 citations · Cited by this paper
  33. Breast cancer and ATM mutations: treatment implications · Marta Seca · 2024 · 9 citations · Cited by this paper
  34. Validation of the pathology-adjusted Manchester scoring system in over 10 000 assessments of cases with breast and/or ovarian cancer · D. Gareth Evans · 2025 · 1 citation · Cited by this paper
  35. Untitled · Cited by this paper

Source: OpenAlex (CC0)